Publication Type:

Journal Article

Source:

Indian Journal of Dermatology, Volume 56, Number 3, p.306-308 (2011)

URL:

http://www.scopus.com/inward/record.url?eid=2-s2.0-79960276337&partnerID=40&md5=e81c250617d5194cc3aa5acecfd91041

Keywords:

add on therapy, adult, alanine aminotransferase, alanine aminotransferase blood level, anemia, article, aspartate aminotransferase, aspartate aminotransferase blood level, C reactive protein, case report, cyclosporin, cytophagic histiocytic panniculitis, dexamethasone, dipeptidyl carboxypeptidase, disease duration, ecchymosis, erythrocyte sedimentation rate, female, ferritin, ferritin blood level, fibrinogen, fibrinogen blood level, follow up, hemoglobin, hemoglobin blood level, human, human tissue, hypertransaminasemia, lactate dehydrogenase, lactate dehydrogenase blood level, leukopenia, liver function test, panniculitis, partial thromboplastin time, prednisolone, prothrombin time, skin biopsy, skin examination, skin necrosis, skin ulcer, subcutaneous tissue, thrombocytopenia

Abstract:

Cytophagic histiocytic panniculitis (CHP) was first described in 1980 by Winkelmann as a chronic histiocytic disease of the subcutaneous adipose tissue, which is characterized clinically by tender erythematous nodules, recurrent high fever, malaise, jaundice, organomegaly, serosal effusions, pancytopenia, hepatic dysfunction, and coagulatory abnormalities. CHP may occur either isolated or as part of cutaneous manifestations of hemophagocytic syndrome. Here, we report two different presentations of CHP.

Notes:

cited By (since 1996)0

Cite this Research Publication

Ja Manoj, Kaliyadan, Fa, Unni, Mb, and Dharmaratnam, A. Da, “Cytophagic histiocytic panniculitis: Report of two cases”, Indian Journal of Dermatology, vol. 56, pp. 306-308, 2011.